| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |